SPRAVATO® is the brand name for esketamine nasal spray, a prescription treatment used for specific depression indications in adults. Unlike a take-home nasal spray, SPRAVATO is administered under healthcare provider supervision in a certified treatment setting with required post-dose monitoring.
For adults with treatment-resistant depression, current U.S. prescribing information allows SPRAVATO to be used either as monotherapy or together with an oral antidepressant. Whether treatment is appropriate depends on diagnosis, prior treatment response, medical history, safety considerations, and clinical evaluation.
Introduction to Spravato
It is a form of nasal spray called esketamine that has been used to treat depression unresponsive to treatment, including standard antidepressants. While the missing segment in standard antidepressants emulates the working of neurotransmitters such as serotonin and dopamine, Spravato comes along to provide a new opportunity that acts on the brain’s glutamate system.
For adults with treatment-resistant depression, SPRAVATO may currently be used as monotherapy or in conjunction with an oral antidepressant. For depressive symptoms in adults with MDD and acute suicidal ideation or behavior, the approved use remains in conjunction with an oral antidepressant.
How Does Spravato Nasal Spray Work?
The only active ingredient of Spravato is esketamine, produced through ketamine, which was previously circulated as an anesthetic. It has subsequently been shown to improve mood conditions, especially among those who do not find solace in standard antidepressant treatment. Spravato modifies the controlling chemicals in the brain regarding all things mood to bring a quick answer to depression in treatment-resistant patients.
Spravato works to relieve symptoms much sooner than potential symptom relief from taking oral medications, which can take some weeks for dosing regimens to show significant effects. Unlike traditional medications that may take weeks to show results, Spravato can sometimes relieve symptoms in just hours. The treatment exploits the brain’s NMDA receptors, which modulate mood and cognition.
Why SPRAVATO May Be Considered for Treatment-Resistant Depression
- Fast Improvement in Depression: The speed at which Spravato takes effect is its most impressive quality. Unlike most conventional antidepressants which may require weeks to show the impact, many individuals report improvement in symptoms within hours of the administration of the nasal spray. Such fast relief can make a significant difference in improving the quality of life for someone who is depressed.
- Effective in Treating Treatment-Resistant Depression: Spravato also works for patients mostly diagnosed with treatment-resistant depression (TRD), which essentially means that they have not found relief using other types of drugs or therapies. Your journey with antidepressants may have been long, with none of the options proving successful. It means you could try Spravato as a treatment option.
- Fewer Side effects: There are indeed fewer side effects from Spravato when compared to conventional antidepressants. The most common symptoms are dizziness, nausea, or some dissociative feeling, but they fade away shortly after the session. Since the treatment is carried out in a clinical environment, it usually has healthcare professionals to monitor the patient and provide other needs related to side effects in the process.
- Easy Administration: Spravato is undoubtedly administered through the nasal spray in a clinic which many might find more innovative because of the subject not being used to oral medications or the very idea of needles. The simple administration process makes Spravato an easy and practical option for many patients.
Does Insurance Cover SPRAVATO Treatment?
Insurance coverage for SPRAVATO varies by health plan, diagnosis, prior treatment history, authorization requirements, and other medical-necessity criteria. Patients should verify benefits and expected out-of-pocket costs before treatment begins.
Lotus Psychiatry & Wellness can discuss the insurance-verification process during evaluation, but coverage should not be assumed until the patient’s specific benefits and authorization requirements have been reviewed.
Is Spravato Right for You?
Before starting Spravato treatment, it’s recommended to consult with a medical doctor. This treatment is most commonly indicated for individuals suffering from extremely severe and treatment-resistant depression, although careful evaluation should be made to determine if the treatment is appropriate for you. Your healthcare professional can help in guiding you through the process, suggesting avenues specific to your current condition.
Patients who want to discuss candidacy, REMS requirements, treatment scheduling, insurance, and clinical evaluation can review Lotus Psychiatry & Wellness’s SPRAVATO treatment service.
Conclusion
Spravato offers new possibilities for those who have long struggled with treatment-resistant depression, without finding relief from traditional medications. With its rapid speed and great ability to deliver relief when other treatments fail, Spravato revolutionizes the existing treatment of depression. Consider Spravato if you could benefit from it; consult a mental health professional to learn about your options for restoring control over your mental well-being.
If you are ready to move from learning about SPRAVATO to discussing whether treatment may be appropriate, review our SPRAVATO treatment evaluation process